United Therap Drug Patent Portfolio
United Therap's Family Patents
Clinical Trials
Recent Clinical Trials by United Therap:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | United Therapeutics | NA |
ENROLLING BY INVITATION
(Sep 1, 2026)
| PHASE3 |
| Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | United Therapeutics | NA |
RECRUITING
(Jul 1, 2026)
| PHASE3 |
| Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) | United Therapeutics | NA |
TERMINATED
(May 1, 2026)
| PHASE3 |
| Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | United Therapeutics | NA |
COMPLETED
(May 1, 2026)
| PHASE3 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List